Mammalian circadian rhythms integrate behavior, physiology and metabolism into daily cycles that are coordinated with the solar day 1 . Circadian timing arises from a genetically encoded oscillator that uses transcriptional feedback loops to generate a self-sustaining clock and control the output of clock-controlled genes, with near-24-h periodicity 2 . At the core of this molecular circadian clock, the heterodimeric basic helix-loop-helix PER-ARNT-SIM (bHLH-PAS) transcription factor CLOCK-BMAL1 drives expression of genes encoding PERIOD (PER) and CRYPTOCHROME (CRY). PER and CRY proteins form complexes that are post-translationally modified to control their stability and their translocation into the nucleus, where they repress transcription mediated by CLOCK-BMAL1, thereby closing the transcriptional feedback loop [3] [4] [5] . However, the mechanisms by which PER and CRY fulfill their roles as negative transcriptional regulators are still not fully understood. In addition to its role in early-repressive PER-CRY complexes, CRY1 also interacts directly with CLOCK-BMAL1 in vitro 6 and binds chromatin later in the circadian cycle 7, 8 , and it can potently repress CLOCK-BMAL1 activity in the absence of PER 9,10 . Therefore, identifying how CRY1 regulates CLOCK-BMAL1 will provide valuable insight into its essential role in the molecular circadian clock.
a r t i c l e s
Mammalian circadian rhythms integrate behavior, physiology and metabolism into daily cycles that are coordinated with the solar day 1 . Circadian timing arises from a genetically encoded oscillator that uses transcriptional feedback loops to generate a self-sustaining clock and control the output of clock-controlled genes, with near-24-h periodicity 2 . At the core of this molecular circadian clock, the heterodimeric basic helix-loop-helix PER-ARNT-SIM (bHLH-PAS) transcription factor CLOCK-BMAL1 drives expression of genes encoding PERIOD (PER) and CRYPTOCHROME (CRY). PER and CRY proteins form complexes that are post-translationally modified to control their stability and their translocation into the nucleus, where they repress transcription mediated by CLOCK-BMAL1, thereby closing the transcriptional feedback loop [3] [4] [5] . However, the mechanisms by which PER and CRY fulfill their roles as negative transcriptional regulators are still not fully understood. In addition to its role in early-repressive PER-CRY complexes, CRY1 also interacts directly with CLOCK-BMAL1 in vitro 6 and binds chromatin later in the circadian cycle 7, 8 , and it can potently repress CLOCK-BMAL1 activity in the absence of PER 9, 10 . Therefore, identifying how CRY1 regulates CLOCK-BMAL1 will provide valuable insight into its essential role in the molecular circadian clock.
Because many factors contribute to the robustness of circadian behavior at the organismal level (for example, intercellular coupling in the suprachiasmatic nucleus and other systemic cues), delineating the biochemical mechanisms needed to establish circadian cycling from in vivo studies has been challenging [11] [12] [13] . For example, BMAL1 (also known as ARNTL) and its partner CLOCK interact through their N-terminal bHLH and tandem PAS domains 14 ; these core bHLH-PAS domains are largely conserved in the paralog BMAL2 (also known as ARNTL2). However, Bmal1 −/− mice (official symbol Arntl) lack all behavioral and molecular circadian rhythms, thus establishing the essential role of BMAL1 in the molecular circadian clock 15 . Although overexpression of Bmal2 (official symbol Arntl2) in Bmal1 −/− mice can partially rescue circadian behavior, paradoxically, it does not restore circadian rhythms in most tissues 16 . Therefore, a fundamental understanding of how core clock proteins function to generate the transcription-based circadian clocks in mammals is still lacking.
The distinct functions of the two BMAL paralogs offer a heuristic opportunity to uncover the properties of CLOCK-BMAL1 that are needed to generate circadian oscillations. To define the circadian function of BMAL1, we used cell-based genetic complementation in Bmal1 −/− fibroblasts derived from mice containing the Per2 Luc transgenic reporter 17 . Domain-based swapping of Bmal1 and Bmal2 revealed the oscillatory function of the BMAL1 C terminus that functionally distinguishes it from its noncircadian paralog, BMAL2. We found that CRY1 binds to the TADs of BMAL paralogs at sites that overlap with binding sites of the coactivator CREB-binding protein (CBP) and its homolog, p300. Mutations within the TAD markedly altered affinities for CRY1 and caused large changes in period length. These findings provide new insights into transcriptional regulation by CRY1 and demonstrate that the BMAL1 TAD plays an important part in establishing 24-h timing.
Only BMAL1 can generate cell-autonomous circadian rhythms Fibroblasts derived from Bmal1 −/− Per2 Luc mice are completely arrhythmic, but circadian rhythms can be restored through genetic complementation of Bmal1 under control of the constitutive UBC promoter (P(UBC)) 17 . Bmal2 was unable to rescue circadian rhythms in these cells, even when its transcript and protein were expressed to similar levels as Bmal1 (Fig. 1a-c and Supplementary  Fig. 1 ). Moreover, Bmal2 was not upregulated under Bmal1 deficiency or upon ectopic expression of Bmal1 (Fig. 1c) , thus indicating a lack of paralog compensation that is a common network feature of genes involved in molecular circadian clocks 18 . As compared to the highamplitude oscillations of Per2 and Rev-erbα (official symbol Nr1d1) mRNA expression in Bmal1-rescued cells, Per2 and Rev-erbα were constitutively expressed in cells expressing Bmal2 but with lower overall mRNA levels, perhaps caused by increased expression of Cry1 in these cells (Fig. 1c) . Overall, these data demonstrate that E box-mediated circadian transcription is substantially attenuated in the absence of Bmal1. Therefore, Bmal1 and Bmal2 are not functionally redundant: Bmal1 is an essential clock component, whereas Bmal2 is not sufficient to support the circadian clock at the cellular level.
BMAL paralogs have similar steady-state activities
To begin to explore differences in the BMAL paralogs, we compared biochemical activities known to be critical for circadian function. Using a mammalian two-hybrid assay, we showed that BMAL2 had a slightly higher intrinsic affinity for CLOCK than BMAL1 (Fig. 1d) . Steady-state transcription assays showed that CLOCK-BMAL2 also activated transcription of the Per1-luciferase (Per1-Luc) reporter to higher levels than CLOCK-BMAL1 (Fig. 1e) , results consistent with previous observations 19, 20 . Increased transcriptional activation by BMAL2 may correlate with its higher affinity for CLOCK, because mutations that decrease the affinity of BMAL1 for CLOCK lead to decreased transactivation 14 . Moreover, complexes of CLOCK with either BMAL1 or BMAL2 were capable of further activation by CBP or p300 and repression by CRY1 (Fig. 1e) . Therefore, even though BMAL2 is unable to support the molecular circadian clock in Bmal1 −/− cells, its steady-state activities appear to be comparable to those of BMAL1. These apparently paradoxical data suggest that a balance of affinities for transcriptional co-regulators may be important for establishing the appropriate strength of activation and repression needed to establish circadian oscillations.
The C terminus of BMAL1 is needed for circadian cycling To identify specific sequences in BMAL1 that confer circadian function, we generated a series of domain-swapped chimeras by systematically substituting regions of Bmal1 with corresponding sequences from Bmal2 (Fig. 2a) . To minimize issues with protein misfolding, we used highly conserved or identical sequences at swap junctions (Supplementary Fig. 2 ) and tested the ability of chimeras to express full-length proteins (Supplementary Fig. 3 ). We then examined the ability of the chimeras to restore circadian rhythms in Bmal1 −/− Per2 Luc fibroblasts after lentiviral transduction and stable selection.
The Bmal1-A2 mutant, containing a substitution of the distal N terminus of Bmal2 into Bmal1, restored circadian rhythms of the same period (Fig. 2b,c) , albeit with significantly lower amplitude than in wild-type (WT) Bmal1 (Supplementary Fig. 3 ), a result possibly arising from the lack of a nuclear localization signal in the BMAL2 N terminus 21 . Chimeras based on swaps of other individual regions within the core bHLH-PAS domains of BMAL2 (i.e., Bmal1-B2, Bmal1-C2, Bmal1-D2, Bmal1-E2 and Bmal1-F2) were all able to rescue circadian rhythms, albeit with some changes in period (Bmal1-D2) 
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Relative activity a r t i c l e s npg a r t i c l e s or amplitude (Bmal1-D2 and Bmal1-E2) depending on the individual region (Fig. 2b,c and Supplementary Fig. 3) . A Bmal1 chimera containing the intact tandem PAS domains from Bmal2 was also able to rescue circadian rhythms (Fig. 2d) . By contrast, substitution of the PAS-domain core of Bmal1 into Bmal2 (the Bmal2-PAS1 mutant) did not allow Bmal2 to generate rhythms (Fig. 2d) .
Together, these data demonstrate that the distal N terminus and bHLH-PAS core domains do not confer the distinct ability to generate circadian rhythms upon BMAL1.
Next we examined the divergent C termini, focusing on the H region, which encompasses a TAD at the distal C terminus 22 , and an upstream G region, which contains the intervening sequence after the PAS domains (Fig. 2a) . Swaps of either the G or H region (Bmal1-G2 and Bmal1-H2) rescued circadian rhythms, but the mutants, as compared to Bmal1, exhibited a significantly shorter period as well as lower amplitude (Fig. 2e,f and Supplementary Fig. 3 ). Strikingly, a Bmal1 chimera fused to the entire C terminus of Bmal2 (Bmal1-G2H2) was unable to restore circadian rhythms of the Per2 Luc reporter (Fig. 2e) or mRNA expression of clock-controlled genes ( Supplementary  Fig. 3) . Therefore, the sequence determinants that distinguish the circadian functions of the two BMAL paralogs lie in their divergent and poorly characterized C termini.
BMAL1 C-terminal TAD determines circadian period
To begin to dissect how the BMAL1 C terminus regulates circadian function, we focused our attention on the TAD of the H region. The ability of the TAD to interact with both negative [22] [23] [24] [25] and positive 26 transcriptional co-regulators enables a clear first step toward understanding how the BMAL1 C terminus may control protein interactions and the progression of circadian transcription. We began by confirming that the TAD is both required for transcriptional activation by 
Period length (h) CLOCK-BMAL1 (ref. 22 ) and necessary to rescue circadian cycling in Bmal1 −/− Per2 Luc fibroblasts ( Supplementary Fig. 3 ).
In our chimera studies, substitution of the Bmal2 TAD (H domain) into Bmal1 gave rise to a circadian period that was more than 3 h shorter than that of WT Bmal1 (Fig. 2f) . Nearly half of the C-terminal 30 residues in the TAD are divergent between BMAL1 and BMAL2 ( Supplementary Fig. 2 ), with many in the predicted α-helix (Fig. 3a) . To identify the sequence determinants that give rise to this dramatic change in period length, we performed site-directed mutagenesis to mutate groups of Bmal1 TAD residues to their corresponding sequences in Bmal2 and tested their ability to rescue circadian rhythms in Bmal1 −/− Per2 Luc fibroblasts. Two Bmal1 mutants, E597S A598I A599D and V602A I603F, exhibited significantly shorter period lengths (~22.5 and ~22.0 h, respectively) compared to that of WT Bmal1 (~23.5 h) (Fig. 3b,e) . The effects of these mutations were nearly additive because the combined Bmal1 mutant (E597S A598I A599D V602A I603F) exhibited a substantially shorter period length (~20.6 h) (Fig. 3c,e) .
The Bmal1 V602A I603F mutant may interfere with the function of the TAD IxxLL recognition motif (Fig. 3a) , a helical sequence known to recruit proteins associated with transcriptional regulation, such as the KIX domain of CBP or p300 (refs. 27,28) . Mutation of the first leucine within the IxxLL motif in the Bmal1 S605N L606Y mutant led to a significantly longer period and higher-amplitude cycling than did WT Bmal1 (Fig. 3d,e) . Therefore, we observed large changes in the period length of the molecular circadian clock (~5 h from shortest to longest) upon incorporation of BMAL2 residues into the BMAL1 TAD α-helix. These data suggest that modulation of TAD structure and/or interactions with transcriptional co-regulators can fine-tune the balance of activation and repression to control progression of the circadian clock.
The BMAL1 TAD is intrinsically unstructured
The striking changes in circadian period elicited by TAD mutations prompted us to investigate the biochemical basis by which the TAD regulates CLOCK-BMAL1 function. The last 30 residues of the TAD are highly conserved between vertebrates and insects that possess a vertebrate-like clock ( Supplementary Fig. 4) , in which transcriptional repression is driven by CRY 29 . Aside from the single α-helix, the BMAL1 TAD (residues 579-626) is predicted to be intrinsically disordered, as is typical of TADs found in other transcription factors 30 . Given the predicted flexibility of this essential domain, we turned to solution NMR spectroscopy to study the TAD. An HSQC spectrum of the 15 N-labeled TAD protein backbone displayed the modest chemicalshift dispersion expected for a disordered protein. We verified the lack of structure by chemical-shift analyses of Cα and Cβ assignments 31, 32 , which confirmed modest helical propensity localized only to the predicted α-helical region (Supplementary Fig. 4 ).
CRY1 and CBP (p300) compete for BMAL1 TAD binding
To examine binding of transcriptional co-regulators on the BMAL1 TAD, we used the CRY1 CC peptide, representing a monomeric surface-exposed α-helix on CRY1 that is needed for CLOCK-BMAL1 repression 33 , or the isolated CBP (p300) KIX domain, one of several TAD-binding modular domains from CBP and p300 proteins ( Supplementary Fig. 4 ). Both the CRY1 CC and CBP (p300) KIX domain have been reported to interact with the BMAL1 TAD 24, 26 . To identify binding sites on the TAD, we collected 15 N HSQC spectra of 15 N-labeled TAD alone or in the presence of co-regulators. Titration of 15 N-TAD with the CRY1 CC or the KIX domains of CBP or p300 led to chemical-shift perturbations at similar residues, thus confirming the interactions and further demonstrating overlapping binding sites on the TAD (Supplementary Fig. 4 ). Marked differences in the linewidth of 15 N-TAD cross-peaks occurred upon binding to co-regulators, particularly at residues in or near the IxxLL motif (for example, V602 and S605; Supplementary Fig. 4) . Because other TADs can undergo a coupled folding-and-binding process to form helical complexes with KIX domains 34 , the observed changes in linewidth upon co-regulator binding reflect different rates of chemical exchange that could arise from changes in affinity, conformational exchange or both.
Chemical-shift mapping revealed that the shared binding sites center on the canonical KIX-binding IxxLL motif within the TAD α-helix as well as on a second cluster of seven residues in the distal C terminus (Fig. 4a,b) . The CRY1-binding sites that we identify here are concordant with results from previous studies that indicate 1:1 stoichiometry of the complex [23] [24] [25] . To determine whether CRY1 and p300 could compete for binding to the TAD, we performed a 15 N HSQC titration with 15 N-TAD and CRY1 CC to a 1:1 stoichiometric ratio and then added an equivalent amount of the p300 KIX domain (Fig. 4c) . 15 N-TAD cross-peaks are expected to fall somewhere between those of the binary 15 N-TAD-CRY1 and 15 N-TAD-KIX complexes, representing a population-weighted average of binary complexes present in solution. We found that 15 N-TAD cross-peaks moved near the 15 N-TAD-KIX complex (Fig. 4c) ; thus, the p300 KIX domain can effectively compete CRY1 CC off the TAD in vitro.
Dynamic interactions of TAD with CRY1 and CBP (p300)
To investigate coupling between the TAD α-helix and the distal C terminus, we took advantage of paramagnetic relaxation enhancement (PRE) with manganese, a paramagnetic cation that induces loss of peak intensity when brought into proximity (~20-25 Å) to NMRactive nuclei. We acquired 15 N HSQC spectra of 15 N-TAD possessing a C-terminal cysteine covalently coupled to EDTA ( 15 N-TAD-EDTA) in the presence and absence of chelated Mn 2+ . Covalent modification of the TAD with EDTA via the added cysteine did not affect complex formation with p300 KIX or CRY1 CC (Supplementary Fig. 5 ). We found no evidence that the distal C terminus interacts appreciably with the α-helix in the free TAD, because Mn 2+ -dependent broadening was confined to residues proximal to the labeling site (Fig. 4d) , consistently with localized PRE effects seen in other disordered proteins 35 . 
npg a r t i c l e s
To determine whether the TAD undergoes dynamic conformational rearrangement upon complex formation, we collected 15 N HSQC spectra of the 15 N-TAD-EDTA ± Mn 2+ titrated with either p300 KIX or CRY1 CC (Supplementary Fig. 5 ). Quantitative analysis of Mn 2+ -dependent changes in peak intensity identified regions near the TAD helix that are decreased upon formation of both 15 N-TADp300 KIX (Fig. 4d) and 15 N-TAD-CRY1 CC complexes (Fig. 4e) . We observed a striking near-complete loss of signal intensity at the TAD α-helix upon binding to CRY1 CC (Fig. 4e) , a result suggesting that the distal C terminus is brought into proximity of the TAD α-helix in a CRY1-dependent manner. A 15 N-TAD mutant lacking the seven residues at the distal C terminus lost this CRY1-and Mn 2+ -dependent broadening of the TAD α-helix (Fig. 4f) , a result demonstrating the dependence of the conformational rearrangement on the distal C terminus. Thus, the BMAL1 TAD is highly dynamic in its interactions with transcriptional co-regulators.
TAD mutations alter affinity for CRY1 and CBP (p300)
To explore functional differences in the TADs of BMAL1 and BMAL2, we generated a suite of mutant proteins to quantitatively compare against WT TAD interactions with transcriptional co-regulators. Like the BMAL1 TAD, the BMAL2 TAD (residues 540-579) is intrinsically disordered with a weakly formed α-helix, and it interacts with both p300 KIX and CRY1 CC at the α-helix as well as at the C-terminal seven residues (Supplementary Fig. 6 ). We focused on two substitution mutants of the BMAL1 TAD α-helix (the short-period V602A I603F mutant and long-period S605N L606Y mutant) (Fig. 3) and two structure-based mutants (the L606A L607A mutant, designed to interfere with the IxxLL motif, and the 619X truncation mutant, which lacks the C-terminal seven residues). In all cases, mutationinduced backbone chemical-shift perturbations localized to the site of mutation, thus demonstrating that we could selectively perturb either the α-helix or the distal C terminus (Supplementary Fig. 6 ).
We determined affinities of the TADs for the CBP KIX domain or CRY1 CC, using isothermal titration calorimetry (ITC, Supplementary  Fig. 7) . Because of the relatively low heats evolved in the TAD-CRY1 CC ITC experiments, we also determined affinities for CRY1 CC with a fluorescence polarization (FP) assay (Supplementary Fig. 7 ) and obtained comparable affinities to our ITC data ( Table 1) . The L606A L607A mutant disrupted interaction with the CBP KIX domain or CRY1 CC under our assay conditions (Fig. 5a,b) . We found that the other TADs had relatively similar affinities for the CBP KIX domain, whereas affinities for CRY1 CC varied by an order of magnitude. Notably, the short-period V602A I603F mutant decreased affinity for CRY1 CC by about three-fold compared to that of the WT BMAL1 TAD, whereas the long-period S605N L606Y mutant increased affinity by about three-fold ( Table 1) . These opposing phenotypes result from substitution of different residues from BMAL2; however, the affinity of the intact BMAL2 TAD was similar to that of the BMAL1 TAD (Table 1) , thus suggesting a complicated interplay of sequence context and structural dynamics in recognition of transcriptional co-regulators by BMAL-paralog TADs. Moreover, truncation of the C-terminal seven residues (619X) decreased affinity for CRY1 CC to an extent similar to that of the V602A I603F mutation. Collectively, these data suggest that the IxxLL motif in the TAD α-helix is the major binding site for both CRY1 CC and CBP (p300) KIX domains, although the distal C terminus also makes an important contribution. The preferential effect of mutations on CRY1 binding relative to CBP (p300) suggests that modulating affinity for CRY1 may elicit the changes in circadian periodicity that we measured in the mutants.
TAD mutations perturb circadian timekeeping
To test our prediction that BMAL1 TAD interactions play an important part in period determination, we complemented Bmal1 −/− Per2 Luc cells with either the C-terminal truncation (619X) or the L606A L607A mutant of Bmal1. Truncation of the C terminus shortened the intrinsic period by nearly 3 h, whereas the L606A L607A mutant abolished cycling (Fig. 5c,d and Supplementary Fig. 7) . Given that these TAD mutations substantially reduce affinity for CRY1 (Table 1) , we sought to measure CRY1 repression of CLOCK-BMAL1 mutants in Per1-Luc reporter assays. CLOCK-BMAL1 complexes containing either L606A L607A or 619X mutation exhibited decreased steadystate activity, although BMAL1 proteins were expressed to similar levels ( Fig. 6a and Supplementary Fig. 8 ). Repression by CRY1 was npg a r t i c l e s significantly reduced with both mutants but was reduced to a greater extent with the L606A L607A mutant (Fig. 6b) , results consistent with our observation that this mutation leads to a greater reduction in apparent affinity for CRY1 ( Table 1) .
CRY1 binds to multiple sites on CLOCK-BMAL1
Formation of a stable ternary complex consisting of CLOCK, BMAL1 and CRY1 lies at the heart of CRY1-dependent negative feedback in the clock 6, 7, 10, 36 . Given the modest affinities that we measured for the BMAL1 TAD and isolated CRY1 CC peptide, we reasoned that there are likely to be other interactions between the CLOCK-BMAL1 complex and CRY1. Mutations that localize in or adjacent to the solvent-exposed HI loop of the CLOCK PAS-B domain (named for its location between the Hβ and Iβ strands of the PAS domain; Fig. 6c ) also reduce repression by CRY1 (refs. 22,25,37) . To determine whether mutation of the CLOCK HI loop (Q361P W362R) affects complex formation with CRY1, we performed coimmunoprecipitation assays to examine the interaction of CRY1-myc with WT or HI-mutant Flag-tagged CLOCK and WT BMAL1. We showed that, although WT CLOCK and BMAL1 coimmunoprecipitated with CRY1-myc, mutation of the CLOCK HI loop rendered CLOCK and BMAL1 unable to stably interact with CRY1-myc ( Fig. 6d and Supplementary  Fig. 8 ). When taken together, our results show that complex formation between CRY1 and CLOCK-BMAL1 occurs through interactions with both the BMAL1 C terminus and CLOCK PAS-B.
To explore how the interaction of CRY1 with CLOCK PAS-B affects the regulation of CLOCK-BMAL1, we assayed Per1-Luc activity. Transcriptional activation by CLOCK HI-BMAL1 complexes and by WT CLOCK-BMAL1 was similar (Fig. 6a,e) , but repression by CRY1 was significantly reduced (Fig. 6f) . Strikingly, we found that mutation of the CLOCK PAS-B HI loop in conjunction with BMAL1 L606A L607A or 619X eliminated repression by CRY1 (Fig. 6f) , even when CRY1 was overexpressed to suprastoichiometric levels relative to CLOCK-BMAL1 (Supplementary Fig. 8 ). We could not detect a direct interaction between CRY1 CC and 15 N-CLOCK PAS-B by NMR spectroscopy (Fig. 6g and Supplementary Fig. 8) , results indicating that the CLOCK PAS-B domain mediates interactions with CRY1 through a site distinct from the CRY1 CC α-helix. Therefore, simultaneous disruption of CRY-interacting interfaces on CLOCK PAS-B and the BMAL1 TAD eliminates CRY1 regulation of CLOCK-BMAL1, thus demonstrating the importance of multivalent interactions for CRY1 repression.
DISCUSSION
Our study leveraged the finding that although BMAL1 and its close paralog BMAL2 share similar steady-state biochemical activities BMAL2 is unable to sustain circadian cycling 15, 17 . This allowed us to discover that the C terminus of BMAL1 holds the key to generating circadian oscillations by BMAL paralogs. By integrating data from biophysical and cell-based assays, we now identify the important role of the BMAL1 TAD in the clock and highlight two distinct binding sites on CLOCK-BMAL1 that are required for CRY1 function. The first site on the CLOCK PAS-B domain presumably functions as a docking site to localize CRY1 to the complex, and the second site on the BMAL1 TAD controls the circadian activity of CLOCK-BMAL1. From the mutations studied here, we find that the affinity of the TAD for CRY1 appears to correlate with period: decreasing affinity leads to shorter periods, whereas increasing affinity leads to longer periods (Fig. 7a) . We find it compelling that substitution of only a few residues within the BMAL1 TAD α-helix can elicit circadian rhythms with periods either shorter or longer than normal (Fig. 7b) , results demonstrating that the TAD has an important role in establishing intrinsic circadian timekeeping. Our observation of opposing period phenotypes encoded by adjacent sequences within the α-helix of the BMAL2 TAD may explain why it is an outlier when CRY1 affinity and period are compared (Fig. 7a) . Additional studies of BMAL1 and BMAL2 TADs that also take into consideration the G region identified in this study will be needed to elucidate the biochemical properties of BMAL1 that enable the dynamic interactions with the co-regulators that underlie the generation of self-sustaining circadian rhythms.
CRY1 appears to fulfill part of its essential role as a negative regulator by interacting directly with CLOCK-BMAL1 to sequester the BMAL1 TAD from coactivators (Fig. 7c) . Here we examined interactions of the BMAL1 TAD with the CBP (p300) KIX domain as a proxy for coactivator recruitment. We expect that our proposed mechanism for CRY1, linking inhibition to TAD sequestration, will hold true for other coactivators and other domains from CBP (p300) that may interact with the BMAL1 TAD. It is worth noting that the related bHLH-PAS transcription factor hypoxia-inducible factor (HIF) uses both TAD-dependent and TAD-independent modes to recruit transcriptional regulators [38] [39] [40] , thus suggesting the potential for additional regulatory mechanisms that control CLOCK-BMAL1 activity. In this context, we note that our model is compatible with studies showing that CRY1 may also interact with additional epigenetic regulators to help achieve complete repression in vivo 41 .
The CRY1 mechanism that we propose here occurs independently of the direct involvement of PER proteins (Fig. 7d) . Recent studies have shown that PER2 sequesters CRY1 away from CLOCK-BMAL1 in vitro and in cells 6, 42, 43 . Two recent CRY structures provide evidence for a possible CLOCK-BMAL1-binding site in the antenna chromophore-binding pocket, which is distinct from the PER2-binding site centered on the CRY1 CC α-helix 23, 44 . Because both PER2 and BMAL1 interact with the CRY1 CC α-helix 23, 24, 33, 44 , our data suggest that a timely handoff between early-repressive PER2-CRY1 complexes [3] [4] [5] 45 to late-repressive CLOCK-BMAL1-CRY1 complexes 7, 8 may represent a critical control mechanism for the molecular circadian clock. We do not discount the importance of PER2 in regulating the stability and timing of nuclear entry of the PER2-CRY1 complexes and the resultant temporal progression of circadian transcriptional repression 46, 47 or roles that CRY1 may have in the PER2-CRY1 complexes 10 .
The precedent for regulation of protein function on the basis of competition for mutually exclusive binding sites exists throughout biology 38, 48 . Competitive mechanisms can make the conversion between inactive and active states more switch-like instead of graded 49 , and switch-like responses that exhibit a high degree of cooperativity amplify rhythms in the molecular circadian clock, thus preventing them from reaching an equilibrium that terminates oscillation 50 . Furthermore, computational models have suggested that tight binding of repressors and activators along with control over protein stoichiometry is key for generation of a robust circadian clock 51 . The remarkable decrease in CRY1 repression that we observed upon disruption of the stable CLOCK-BMAL1-CRY1 complex (Fig. 6f) illustrates how important ternary-complex formation is for repression when CRY is expressed at near-stoichiometric levels with the CLOCK-BMAL1 complex in vivo 52 .
It is well recognized that changes in clock-protein abundance, posttranslational modifications and subcellular localization have critical roles in circadian timekeeping 36 . Our data suggest that conformational dynamics also plays a critical part in period determination, because disordered regions can easily coordinate protein interactions with diverse co-regulators by coupling folding to binding 34, 53 . Modest changes in the intrinsic secondary structure of other TADs affect the npg a r t i c l e s thermodynamics of binding to CBP (p300) to influence the temporal basis (i.e., transient or constitutive) of coactivation 54, 55 . Therefore, the structural dynamics that we observe within the BMAL1 TAD could play an interesting part in setting the timescale of activation and repression to ultimately contribute to circadian timing. 
METHODS

Methods
ONLINE METHODS
Lentiviral DNA constructs, preparation and transduction. Bmal1 and UBC promoters were cloned into the pENTR-5′-TOPO vector (Life Technologies), as described before 17 . Mouse Bmal1, Bmal2 and various chimeras or mutants were first subcloned into p3×Flag-CMV-10 or p3×Flag-CMV-14 vectors to obtain 3×-Flag tags at the N or C termini, respectively, and then cloned into the pENTR/D-TOPO vector (Life Technologies). The promoter and cDNA pENTR vectors were recombined with pLV7 destination vector 56 with Clonase (Life Technologies) to generate the lentiviral expression constructs. All constructs were verified by sequencing of the entire open reading frame.
Recombinant lentiviral particles were produced by transient transfection in human embryonic kidney HEK293T cells (ATCC) with the calcium-phosphate method, as previously described 56, 57 . The Bmal1 −/− Per2 Luc mouse fibroblast cell line was generated in our previous studies 17 . Cells were cultured in DMEM supplemented with 10% FBS and 1× penicillin-streptomycin-glutamine mixture. All cell-culture reagents were from HyClone. For infection of Bmal1 −/− Per2 Luc fibroblasts, culture medium containing viral particles (~10 6 viral particles/ml) were harvested 48 h after transfection and used for subsequent infection of cells. Transduced cells were selected with 10 µg/ml blasticidin (InvivoGen) as previously described 17 .
Luminescence recording and data analysis. We used a LumiCycle luminometer (Actimetrics) for luminescence recording as previously described 56 . Cells were grown to confluence in 35-mm dishes before recordings. The recording medium contained 1× DMEM, 25 mM HEPES, pH 7.4, 1% FBS, 1× B-27 and 1 mM luciferin, as previously described 17 . Three independent clonal lines and two or three dishes for each clone were tested to validate phenotypes. Raw luminescence data (counts/s) as a function of time (d) in culture were analyzed with the LumiCycle Analysis program (version 2.53, Actimetrics) to determine circadian parameters. Owing to high transient luminescence upon medium change, the first cycle was excluded from analysis. Briefly, raw data were fitted to a linear baseline, and the baseline-subtracted data were fitted to a damped sine wave, from which period length, goodness of fit, and damping constants were determined. A goodness of fit of >80% was usually achieved from samples that showed persistent rhythms. Damping rate is described by the value of 1/damping constant. For amplitude analysis, raw data from days 3-5 were fitted to a linear baseline (polynomial number = 1), and the baseline-subtracted data were fitted to a sine wave, from which amplitude was determined.
Transient transfection and reporter assays. Reporter assays investigating steady-state differences between Bmal1 and Bmal2 function were performed with HEK293T cells in triplicate on 384-well plates. For mammalian two-hybrid assays, 12.5 ng of pGL4P-4×UASøLuc, 2.5 ng Renilla luciferase (RLuc) plasmid, 25 ng pACT and 25 ng pBIND were used in each well as previously described 25 . The Per1-Luc reporter assay was performed as reported elsewhere with minor modifications 25 . For each well, 12.5 ng Per1-Luc reporter, 25 ng pLV7-P(UBC)-mouse Bmal, 25 ng pLV7-P(CAG)-mouse Clock, 25 ng pcDNA-CMV-mouse p300 or Cbp, 25 ng pLV156-P(CMV)-mouse Cry1, and 2.5 ng RLuc were used. When needed, empty vectors were included to make up 115 ng of total plasmid amount. RLuc was used for reporter normalization. In assays with Cry1, indicated amounts of pLV156-P(CMV)-Cry1 were compensated with empty pLV7 destination vector to a total of 50 ng. Lipofectamine 2000 (Life Technologies) was used with a reverse-transfection protocol. Reporter assays were performed 24 h after transfection with DualGlo luciferin reagent (Promega), and luciferase reporter activity was normalized with Renilla luciferase.
To compare expression of Flag-tagged Bmal1 genes, cells were lysed in RIPA buffer containing complete protease and phosphatase inhibitors (Sigma). Immunoblotting was done with the primary antibodies mouse anti-Flag antibody (M2) (Sigma cat. no. F3165) or goat anti-β actin (C-11) (Santa Cruz Biotechnology cat. no. sc-1615), and the secondary antibodies anti-mouse IgG-HRP (Santa Cruz Biotechnology cat. no. sc-2005) or anti-goat IgG-HRP (Santa Cruz Biotechnology cat. no. sc-2020). Antibody validation is provided on the manufacturers' websites. SuperSignal West Pico substrate (Pierce) was used for chemiluminescent detection on autoradiograph film.
For coimmunoprecipitation assays, plasmids were transfected into HEK293T cells in a 35-mm dish with LT-1 transfection reagent (Mirus) with the indicated plasmid ratios: 1.5 µg each pSG5 mouse Flag-Bmal1 and pSG5 mouse His 6-Flag-Clock, plus 50 ng pcDNA3-mouse Cry1 (no tag; used for anti-Flag IP) or 250 ng pcDNA4-Cry1 (C-terminal Flag, myc, His 6 tagged; used for anti-myc IP). Cells were harvested 48 h later for coimmunoprecipitation with anti-myc (9E10) (distributed by the Developmental Studies Hybridoma Bank at the University of Iowa, cat. no. 9E 10-a) or anti-Flag antibody (Sigma). Briefly, cells were lysed on ice for 15 min in 250 µl 50 mM HEPES, pH 7.5, 150 mM NaCl, 5% (v/v) glycerol, 0.5% (v/v) NP-40 and EDTA-free protease inhibitors (RPI Biochemicals). Clarified extracts were added to 300 µl lysis buffer containing 1 µg of anti-myc monoclonal antibody plus 15 µl Protein A/G resin (Santa Cruz Biotechnology) or 15 µl anti-Flag M2 affinity resin (Sigma cat. no. A2220) after 25 µl was retained as the input sample. Tubes were rotated end over end for 4 h, and resin was washed three times with 400 µl lysis buffer. Proteins were eluted from resin by addition of 30 µl 2× SDS Laemmli buffer and were boiled for 3 min. Complexes were resolved by 7.5% SDS-PAGE after transfer to nitrocellulose. Proteins were detected by immunoblotting with the primary antibodies mouse anti-myc, mouse anti-Flag, rat anti-CRY1 (a gift from A. Sancar) 58 , mouse anti-BMAL1 (B-1) (Santa Cruz Biotechnology cat. no. sc-365645), or rabbit anti-CLOCK (H-276) (Santa Cruz Biotechnology cat. no. sc-25361), and the secondary antibodies anti-mouse IgG-HRP (Sigma cat. no. A9917), anti-rabbit IgG-HRP (Sigma cat. no. A0545), or anti-rat IgM-HRP (Thermo Fisher cat. no. 31476). Validation of commercial antibodies is provided on the manufacturers' websites. Clarity reagent (Bio-Rad) was used for chemiluminescent detection on a ChemiDoc XRS+ imager (Bio-Rad). All data shown are representative of three independent experiments.
For Per1-Luc reporter-gene assays investigating CRY1 repression, plasmids were transfected in duplicate into HEK293T cells in a 48-well plate with LT-1 transfection reagent (Mirus) with the indicated plasmids: 5 ng pGL3-Per1-Luc reporter 59 , 100 ng each pSG5 Flag-Bmal1 and pSG5 His 6-Flag-Clock, and pcDNA3 Cry1 (untagged) in increasing amounts as indicated; empty pcDNA4 vector was used to normalize total plasmid to 800 ng/well. Cells were harvested 30 h after transfection with Passive Lysis Buffer (NEB), and luciferase activity was assayed with Bright-Glo luciferin reagent (Promega). Each reporter assay was repeated at least three independent times. To compare relative expression of CLOCK, BMAL1, and CRY1 proteins, a 12-well plate of HEK293T cells was transfected with 400 ng each pSG5 His 6-Flag-Clock and Flag-Bmal1 with pcDNA4B Cry1 (C-terminal Flag, myc, His 6 epitope tags) 60 as indicated, with empty pcDNA4 vector to normalize plasmid concentration to 1 µg total DNA. Cells were harvested 48 h later for immunoblotting with anti-Flag antibody, anti-BMAL1 (B-1), and anti-CLOCK (H-276) antibodies. Immunoblot of relative expression in Supplementary Figure 8 is representative of two independent experiments.
All cell lines used in the study were routinely checked for mycoplasma contamination. Original images of autoradiographs and blots used in this study can be found in Supplementary Data Set 1. qPCR analysis. Cells were synchronized with 200 nM dexamethasone, and the first time point was collected 24 h later, as previously described 17 . Total RNAs were prepared with the RNeasy 96 kit (Qiagen). High-capacity RNA to cDNA Kit (Applied Biosystems) was used for reverse transcription, and qPCR was performed with SYBR Green PCR master mix (Thermo Scientific) on an iCycler thermal cycler (Bio-Rad). Transcript levels for each gene were normalized to Gapdh, and values were expressed as percentage of expression, as indicated.
Expression and purification of recombinant proteins. Proteins were expressed in Escherichia coli Rosetta2 (DE3) cells from a pET22b vector backbone (EMD Millipore). Mouse BMAL1 TAD (residues 579-626), BMAL2 TAD (residues 540-579), and p300 KIX (residues 565-653) domains all possessed an N-terminal TEV-cleavable His 6 -GST or His 6 -SUMO tag. Mutations were introduced by site-directed mutagenesis and confirmed by sequencing. The plasmid encoding untagged mouse CBP KIX was a gift from P.E. Wright. CBP KIX protein was expressed in Rosetta (DE3) cells overnight at 18 °C after IPTG induction, and the soluble fraction was purified on Ni-NTA resin as described above with native histidine residues on CBP KIX. Cells were grown in either LB medium or M9 minimal medium containing 1 g/L 15 NH 4 Cl for uniform 15 N labeling, as described before 40 ; for triple-resonance experiments, uniformly 13 
